CPT Guidance for QuantiFERON TB Gold Plus

An audit in medical billing is a structured review of documentation, coding, charges, claims, payments, denials, and related workflow records. For an infectious disease practice, an audit may examine whether the billed service is supported by the record, whether charge capture is complete, and whether payer responses align with the submitted claim. The purpose is to identify errors, compliance concerns, missed revenue, and process improvements.

The appropriate CPT code should be determined from the specific laboratory service performed, the reporting circumstances, payer guidance, and the documentation available to support the claim. QuantiFERON TB Gold Plus is a laboratory test, but practices should not select a code solely from the product name. Confirm the current CPT code set, laboratory reporting arrangement, payer policy, and whether the practice or an outside laboratory performed and billed the service.

Medical necessity documentation should explain why tuberculosis testing was clinically appropriate for the patient and encounter. The record may need to support the relevant symptoms, exposure concern, screening context, risk assessment, or infectious disease evaluation, depending on the circumstances. Documentation and payer expectations can vary, so practices should align the claim with the actual clinical record and applicable policy rather than relying on a generic diagnosis or template.

Whether an infectious disease practice can bill directly depends on who performed the laboratory work, who owns or operates the testing arrangement, applicable enrollment and billing requirements, and the payer’s rules. If an outside laboratory performs or bills the test, the practice’s claim workflow may involve reporting the professional service separately when supported. Review the operational arrangement, documentation, payer policy, and applicable billing guidance before submitting charges.

Supporting documentation should connect the test to the patient’s clinical situation and show that the service was ordered or performed as documented. Relevant records may include the assessment, reason for testing, associated diagnosis or clinical concern, order information, test result, and details identifying the billed service. Practices should also retain records needed to explain laboratory responsibility and resolve payer questions when a claim is denied or questioned.

Denial prevention starts with a consistent workflow linking the order, clinical documentation, diagnosis selection, laboratory details, charge entry, and payer requirements. Practices can review recurring rejection and denial reasons, check whether authorization or coverage rules apply, and confirm that the claim reflects the service actually performed. Tracking root causes helps teams correct upstream documentation or charge-capture issues instead of repeatedly resubmitting the same problem.

Payment review should compare the submitted service and supporting documentation with the payer response, including adjudication details, allowed amounts when available, patient responsibility, adjustments, and denial or rejection messages. A practice can organize findings by payer, service line, and claim status to identify patterns. The review should use the practice’s own contracts, remittance information, and verified data rather than generalized reimbursement assumptions.

No. CPT guidance identifies the reported service, but reimbursement can also depend on documentation, diagnosis support, payer policy, contract terms, billing responsibility, claim submission details, and whether the service falls under a particular coverage arrangement. Practices should treat CPT selection as one part of a broader revenue-cycle workflow. Any payment expectation should be based on applicable payer information and the practice’s own verified records.